ARTICLE | Company News
Genaera endocrine, inflammation news
April 16, 2007 7:00 AM UTC
GENR restructured and reduced its headcount by 10 (30%) to 23 to focus on developing trodusquemine ( MSI-1436), a protein tyrosine phosphatase 1B ( PTP-1B) inhibitor in preclinical development to tr...